Summary
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Turkey. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Turkish healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The Turkish pharmaceutical market increased from TRY13.6B in 2011 to TRY30.9B in 2018 at a Compound Annual Growth Rate (CAGR) of 12.4%. However, in US dollars, the pharmaceutical market was $8.1B in 2010, which decreased to $6.4B in 2018 at a negative CAGR of 3.4%. The difference in the values is due to the drop in value of the Turkish Lira against the US Dollar.
The Turkish medical device market was valued at $3.28B in 2015, which increased slightly to $3.69B in 2017. The market is expected to grow at a CAGR of 4% from $3.83B in 2019 to $3.97B in 2020. The pharmaceutical market is primarily driven by continued strong domestic demand backed by expansionary economic policies. The Turkish government continues to use localization policies to increase domestic production of medicines and vaccines.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Turkey, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, Pfizer, Novartis, GSK, and Abdi Ibrahim) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Essilor, and Zimmer Biomet)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Turkey
- Porter’s five forces analysis for pharmaceutical and medical devices market of Turkey
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Turkish healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Turkish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Turkish healthcare market
'
Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Events: Turkish Pharmaceutical History, 2008-2017
2.4 Key Events: Turkish Pharmaceutical Market
2.5 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, Turkey, 2018
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Major Therapeutic Areas
3.7 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Top Five Segments
4.3 Medical Device Market - Diagnostic Market
4.4 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Turkey
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Turkey
7 Pharmaceutical and Medical Device Market - Porter’s Five Forces Analysis
7.1 Pharmaceutical Market, Turkey - Porter’s Five Forces Analysis
7.2 Medical Device Market, Turkey - Porter’s Five Forces Analysis
8 Market Access
8.1 Drug Reimbursement Process, Turkey
8.2 Overview of Health Insurance, Turkey
8.2.1 Healthcare Spending and Health Price Index, Turkey
8.2.2 Pricing Policies, Turkey
8.3 Regulatory Landscape, Turkey
8.3.1 Market Authorization for Pharmaceutical Drugs, Turkey
8.3.2 Market Authorization for Medical Devices, Turkey
8.3.3 Licensing Process for Medical Products
8.3.4 Intellectual Property Rights, Patent, Turkey
8.3.5 Intellectual Property Rights, Trademark, Turkey
8.3.6 Clinical Trial Regulations, Turkey
8.3.7 Pharmaceutical Clinical Trials Landscape, Turkey
8.3.8 Medical Devices Clinical Trials Landscape, Turkey
8.3.9 Pharmaceutical Advertising Regulations, Turkey
8.3.10 Labeling and Packaging Regulations, Turkey
9 HealthTech Landscape
9.1 HealthTech Deals Landscape, Turkey
9.1.1 Key HealthTech Deals, Turkey
10 Country Healthcare Landscape
10.1 Healthcare Policy Highlights
10.2 Healthcare Facilities
10.3 Healthcare Parameters
10.4 Environmental Health
10.5 Healthcare Personnel
10.6 Disease Burden
10.7 Healthcare Expenditure
11 Trade Associations, Turkey
12 Trade Fairs, Turkey
13 Opportunities and Challenges
14 Appendix
14.1 Research Methodology
14.1.1 Coverage
14.1.2 Secondary Research
14.1.3 Forecasts
14.1.4 Expert Panel
14.2 Bibliography
14.3 Contact Us
14.4 Disclaimer
List of Tables
Table 1: Top Therapeutical Areas by Pharmaceutical Consumption (%), Turkey, 2018
Table 2: Ophthalmic Devices Market, Turkey, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 3: Merger & Acquisition Deals, Medical Device Market, Vietnam, 2018-2019
Table 4: Social Security Premiums (%), Turkey, 2016
Table 5: Profit Rates for Drug Pricing, Turkey, 2018
Table 6: Licensing Fees, Turkey, 2018
Table 7: Patent Fees, Turkey, 2019
Table 8: Differences between Industrial Property Law and Decree No 556 for Protection of Trademark, Turkey, 2019
Table 9: Trade Fairs, Turkey, 2019
List of Figures
Figure 1: Pharmaceutical Market, Turkey, Revenue ($B), 2011-2018
Figure 2: Medical Device Market, Turkey, Revenue ($B), 2015-2020
Figure 3: Country Profile, Turkey, 2018
Figure 4: Pharmaceutical Market, Turkey, Revenue ($B), 2011-2018
Figure 5: Pharmaceutical Market, Turkey, Revenue Forecast ($B), 2019-2022
Figure 6: Pharmaceutical Exports ($B), Turkey, 2010-2018
Figure 7: Top Export Partners, Turkey, 2018
Figure 8: Pharmaceutical Imports ($B), Turkey, 2010-2018
Figure 9: Top Import Partners, Turkey, 2018
Figure 10: Trace and Track System, Turkey, 2019
Figure 11: Generic Drugs Market ($B), Turkey, 2011-2018
Figure 12: Generic vs. Originator Drug Share (%), Turkey, 2010-2018
Figure 13: Biotechnological Drugs Market ($M), Turkey, 2011-2018
Figure 14: Biosimilars Market Share (%), Turkey, 2018
Figure 15: OTC Market, Turkey, Revenue ($B), 2010-2018
Figure 16: OTC Market by Drug Category, Turkey, Revenue ($M), 2018
Figure 17: Top Therapeutical Areas by Pharmaceutical Consumption (%), Turkey, 2018
Figure 18: Pharmaceutical Market, Major Players, 2017
Figure 19: Medical Device Market, Turkey, Revenue ($B), 2015-2018
Figure 20: Medical Device Market, Turkey, Revenue Forecast ($B), 2019-2022
Figure 21: Medical Device Market, Turkey, Revenue by Segment ($M), 2018
Figure 22: Orthopedic Devices Market, Turkey, Revenue ($M), 2015-2022
Figure 23: Wound Care Management Market, Turkey, Revenue ($M), 2015-2022
Figure 24: Ophthalmic Devices Market, Turkey, Revenue ($M), 2015-2022
Figure 25: Ophthalmic Devices Market, Turkey, Market Share of Major Players (%), 2015
Figure 26: Cardiovascular Devices Market, Turkey, Revenue ($M), 2015-2022
Figure 27: In Vitro Diagnostics Management Market, Turkey, Revenue ($M), 2015-2022
Figure 28: Diagnostic Market, Turkey, Revenue ($M), 2015-2020
Figure 29: Diagnostic Market, Turkey, Revenue ($M), 2021-2025
Figure 30: Medical Device Market, Turkey, Revenue ($B) of Major Companies, 2017
Figure 31: Deal Value and Deal Count, Pharmaceutical Market, Turkey, 2018-2019
Figure 32: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Turkey, 2018-2019
Figure 33: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Turkey, 2018-2019
Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Turkey, 2018-2019
Figure 35: Drug Reimbursement Process, Turkey, 2018
Figure 36: Social Security System, Turkey, 2016
Figure 37: Healthcare Services under UHI, Turkey, 2016
Figure 38: Out-of-Pocket Expenditure ($ per capita), Turkey, 2010-2017
Figure 39: Annual Rate of Change (%), Health Price Index, Turkey, 2010-2018
Figure 40: Drug Pricing Process, Turkey, 2018
Figure 41: Ministry of Health, Organization Chart, 2018
Figure 42: Drug Approval Process, Turkey, 2018
Figure 43: Medical Device Draft Regulation, Turkey, 2019
Figure 44: Medical Device Classes, Turkey, 2019
Figure 45: Trademark Approval Process, Turkey, 2019
Figure 46: Pharmaceutical Clinical Trials Count By Trial Status, Turkey, 2018-2019
Figure 47: Pharmaceutical Clinical Trials Count By Phase, Turkey, 2018-2019
Figure 48: Pharmaceutical Clinical Trials Count By Therapy Area, Turkey, 2018-2019
Figure 49: Top Five Pharmaceutical Clinical Trials Sponsor By Count, Turkey, 2018-2019
Figure 50: Medical Devices Clinical Trials Count By Trial Status, Turkey, 2018-2019
Figure 51: Medical Devices Clinical Trials Count By Category, Turkey, 2018-2019
Figure 52: Medical Devices Clinical Trials Count By Indication, Turkey, 2018-2019
Figure 53: Top Five Medical Clinical Trials Sponsor By Count, Turkey, 2018-2019
Figure 54: Packaging and Labeling information, Turkey, 2017
Figure 55: Deal Value, HealthTech, Turkey, 2018-2019
Figure 56: Deal Count, HealthTech, Turkey, 2018-2019
Figure 57: Deal Count by Technology Theme, HealthTech , Turkey, 2018-2019
Figure 58: Hospitals (number), Turkey, 2010-2017
Figure 59: Hospitals by Type (number), Turkey, 2010-2017
Figure 60: Diagnostic Equipment (units per million population), Turkey, 2010-2017
